Deal Roundup: Bain Capital, Cinven-backed Stada could launch IPO within days, Carlyle’s Energean assets deal under threat

Bain Capital and Cinven-owned German pharmaceutical business Stada could launch its IPO as soon as Wednesday, with an expected company valuation of between €10bn and €12bn.